Search
for
Sort by
Research 30 of 112
- Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)
- Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)
- Psychotropic Medications and the Skin
- Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome?
- Management of Hiccups After Hair Restoration
- Nurses' Drug Alert
- Factitial Leg Ulcers Associated With an Unusual Sleep Disorder
- Anti-anginal and beta-adrenoceptor blocking drugs
- A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
- Adverse Cutaneous Reactions to Antipsychotics
- Treatment of Tourette’s Syndrome With Finasteride
- Sights for Sore Eyes and Disappointments in Psychopharmacology
- Diffuse hair loss associated with hyperprolactinaemia: report of three cases
- The Neurobiology of Sexual Function
- Drug-Induced Skin, Nail and Hair Disorders
- Adverse effects of common medications on male fertility
- Oral Manifestations of Hematologic and Nutritional Diseases
- The Pharmacologic Treatment of Muscle Pain
- TOXIC EPIDERMAL NECROLYSIS
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- Adverse Cutaneous Reactions to Antidepressants
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Combination Therapies and the Theoretical Limits of Evidence-Based Medicine
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Intraoperative Floppy Iris Syndrome: Updated Perspectives
- Trichotillomania: Clinical Aspects and Treatment Strategies *
- Psychodermatology
- Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- An Update on Drug-Induced Pigmentation